Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney

被引:1
|
作者
Miyata, T [1 ]
Sugiyama, S
Nangaku, M
Suzuki, D
Uragami, KI
Inagi, R
Sakai, H
Kurokawa, K
机构
[1] Tokai Univ, Sch Med, Inst Med Sci, Isehara, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Dept Internal Med, Isehara, Kanagawa 2591193, Japan
[3] Chukyo Hosp, Dept Nephrol, Nagoya, Aichi, Japan
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1999年 / 10卷 / 07期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Lipid abnormalities are associated with various dis orders ranging from generalized atherosclerosis to renal diseases, including lipoprotein glomerulopathy that is characterized by glomerular lipoprotein thrombi and causes type III hyperlipoproteinemia, proteinuria, and renal failure. This study examines lipoprotein glomerulopathy, which recurred in a transplanted kidney. Molecular biologic analysis of the patient's apolipoprotein (apo) E gene demonstrated E2/E5 type variants. Immunohistochemical analysis of the diseased kidney demonstrated various lipid peroxidation-specific protein adducts, suggesting a potential role of oxidative stress in this disorder. Recurrence in the transplanted kidney suggested a pathogenic role of extraglomerular humoral component(s) resulting from abnormal lipoprotein metabolism, presumably linked to apo E and other genetic or acquired factor(s). Furthermore, the finding that the patient showed pathologic abnormalities in the transplanted kidney with no clinical signs or symptoms of renal disease indicated that lipoprotein glomerular damage progresses early before any clinical manifestations.
引用
收藏
页码:1590 / 1595
页数:6
相关论文
共 50 条
  • [1] A novel apolipoprotein E2 variant is related to lipoprotein glomerulopathy
    Matsunaga, A
    Sasaki, J
    Tsuji, E
    Moriyama, K
    Koga, T
    Doi, T
    CIRCULATION, 1998, 98 (17) : 238 - 239
  • [2] A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy
    Matsunaga, A
    Sasaki, J
    Komatsu, T
    Kanatsu, K
    Tsuji, E
    Moriyama, K
    Koga, T
    Arakawa, K
    Oikawa, S
    Saito, T
    Kita, T
    Doi, T
    KIDNEY INTERNATIONAL, 1999, 56 (02) : 421 - 427
  • [3] A patient with apolipoprotein E2 variant (Q187E) without lipoprotein glomerulopathy
    Hayakawa, M
    Okubo, M
    Katori, H
    Nagahama, K
    Murase, T
    Kobayashi, T
    Tanaka, S
    Nakanishi, K
    Odawara, M
    Matsushita, H
    Yamada, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03)
  • [4] Lipoprotein glomerulopathy: Renal lipidosis induced by novel apolipoprotein E variants
    Saito, T
    Oikawa, S
    Sato, H
    Sasaki, J
    NEPHRON, 1999, 83 (03) : 193 - 201
  • [5] Role of apolipoprotein E variants in lipoprotein glomerulopathy and other renal lipidoses
    Saito T.
    Ishigaki Y.
    Oikawa S.
    Yamamoto T.T.
    Clinical and Experimental Nephrology, 2001, 5 (4) : 201 - 208
  • [6] Lipoprotein glomerulopathy: A new role for apolipoprotein E?
    Karet, FE
    Lifton, RP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (05): : 840 - 842
  • [7] Lipoprotein Glomerulopathy Associated with a Mutation in Apolipoprotein E
    Magistroni, Riccardo
    Bertolotti, Marco
    Furci, Luciana
    Fano, Rita Adriana
    Leonelli, Marco
    Pisciotta, Livia
    Pellegrini, Elisa
    Calabresi, Laura
    Bertolini, Stefano
    Calandra, Sebastiano
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2013, 6 : 189 - 196
  • [8] A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy
    T. Ogawa
    K. Maruyama
    H. Hattori
    H. Arai
    I. Kondoh
    T. Egashira
    T. Watanabe
    Y. Kobayashi
    A. Morikawa
    Pediatric Nephrology, 2000, 14 : 149 - 151
  • [9] A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy
    Ogawa, T
    Maruyama, K
    Hattori, H
    Arai, H
    Kondoh, I
    Egashira, T
    Watanabe, T
    Kobayashi, Y
    Morikawa, A
    PEDIATRIC NEPHROLOGY, 2000, 14 (02) : 149 - 151
  • [10] Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy
    Saito, T
    Ishigaki, Y
    Oikawa, S
    Yamamoto, TT
    TRENDS IN CARDIOVASCULAR MEDICINE, 2002, 12 (02) : 67 - 70